The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy

Abramson Cancer Center at Penn Medicine1 site in 1 country204 target enrollmentSeptember 2012

ConditionsNon-small Cell Lung Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Non-small Cell Lung Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
Enrollment: 204
Locations: 1
Primary Endpoint: To Describe the Pattern of CTCs Before and After Definitive Radiotherapy for Each Treatment Stratum
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

CTC levels collected pre-surgery will be correlated with pathological samples.

Detailed Description

Patients with NSCLC who undergo radiation as part of a definitive course of treatment will be enrolled. Blood collections will be obtained before, during, and after radiotherapy. We will collect demographic and treatment data and explore \& describe the pattern of CTC detection in all patients

Registry

clinicaltrials.gov

Start Date

September 2012

End Date

December 2021

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Abramson Cancer Center at Penn Medicine

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients with biopsy-proven NSCLC who are undergoing definitive radiotherapy as a part of their treatment regimen.
•Age 18 or older
•Signed informed consent
•Patients who are incapable of providing informed consent are excluded from participating in this study.